PAVmed Stock Forecast

PAVM's stock price has decreased by -74.47% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

According to 2 analysts polled by S&P Global, PAVmed stock has a consensus rating of "Buy" and an average price target of $36. The average 1-year stock price forecast is 645.34% higher than the current stock price, while the lowest is $16 (+231.26%) and the highest is $56 (+1,059.42%).

Price Target: $36 (+645.34%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$16	$36	$36	$56
Change	+231.26%	+645.34%	+645.34%	+1059.4%

Analyst Ratings

The average analyst rating for PAVmed stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Dec '25	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	1	1	1	1	1	1
Buy	1	0	1	1	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	1	2	2	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Anthony Vendetti Maxim Group	Maxim Group	Buy Reiterates $16	Buy	Reiterates	$16	+231.26%	May 19, 2026
Edward Woo Ascendiant	Ascendiant	Buy Maintains $510 → $65	Buy	Maintains	$510 → $65	+1,245.76%	Apr 8, 2026

Financial Forecast

Revenue This Year

340.00K

from 71.00K

378.87%

from 71.00K

Revenue Next Year

652.50K

from 340.00K

91.91%

from 340.00K

EPS This Year

-2.62

from -4.69

EPS Next Year

-2.45

from -2.62

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	500.00K	377.00K	2.45M	3.00M	71.00K	340.00K
Revenue Growth	-	-24.60%	550.40%	22.15%	-97.63%	378.87%
Gross Profit	-85.00K	-3.24M	-3.97M	-1.85M	-147.00K	66.98K
Gross Margin	-17.00%	-858.62%	-161.83%	-61.60%	-207.04%	19.70%
Operating Income	-54.39M	-91.09M	-68.80M	-44.49M	-21.81M	-26.33M
Net Income	-50.35M	-88.98M	-64.18M	39.79M	401.00K	-20.96M
EPS	-	-	-	-	-4.69	-2.62
Free Cash Flow	-22.18M	-39.42M	-27.92M	-20.32M	-14.00M	1.90M
No. Analysts	-	-	-	-	-	2

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	480,000
Avg	340,000
Low	200,000

Revenue Growth

Revenue Growth	2026	2027	2028
High	576.1%
Avg	378.9%
Low	181.7%

EPS Forecast

EPS	2026	2027	2028
High	-2.62
Avg	-2.62
Low	-2.62

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-